In the last trading session, 85533.0 shares of the 180 Life Sciences Corp (NASDAQ:ATNF) were traded. Most recently the company’s share price was $1.56, and it changed around -$0.02 or -1.27% from the last close, which brings the market valuation of the company to $4.96M. ATNF currently trades at a discount to its 52-week high of $17.75, offering almost -1037.82% off that amount. The share price’s 52-week low was $1.16, which indicates that the current value has risen by an impressive 25.64% since then. We note from 180 Life Sciences Corp’s average daily trading volume that its 10-day average is 0.31 million shares, with the 3-month average coming to 962.20K.
180 Life Sciences Corp stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 0 recommended ATNF as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight.
180 Life Sciences Corp (NASDAQ:ATNF) trade information
Instantly ATNF has showed a red trend with a performance of -1.27% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 1.6700 on recent trading dayincreased the stock’s daily price by 6.59%. The company’s shares are currently down -14.29% year-to-date, but still up 3.31% over the last five days. On the other hand, 180 Life Sciences Corp (NASDAQ:ATNF) is -14.29% down in the 30-day period. We can see from the shorts that 0.14 million shares have been sold at a short interest cover period of 0.03 day(s).
ATNF Dividends
180 Life Sciences Corp’s next quarterly earnings report is expected to be released in February.
180 Life Sciences Corp (NASDAQ:ATNF)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 4.34% of 180 Life Sciences Corp shares, and 3.45% of them are in the hands of institutional investors. The stock currently has a share float of 3.61%.
